Tower Research Capital (TRC)’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $2.84K | Buy |
|
|||||
|
2024
Q1 | $22.1K | Buy |
|
|||||
|
2023
Q4 | $545 | Sell |
|
|||||
|
2023
Q3 | $7.4K | Buy |
|
|||||
|
2023
Q2 | $8.62K | Buy |
|
|||||
|
2023
Q1 | $4K | Sell |
|
|||||
|
2022
Q4 | $10K | Buy |
|
|||||
|
2022
Q3 | $9K | Buy |
|
|||||
|
2022
Q2 | $11K | Buy |
|
|||||
|
2022
Q1 | $2K | Sell |
|
|||||
|
2021
Q4 | $7K | Sell |
|
|||||
|
2021
Q3 | $97K | Buy |
|